File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Retinopathy of prematurity: Applicability and compliance of guidelines in Hong Kong

TitleRetinopathy of prematurity: Applicability and compliance of guidelines in Hong Kong
Authors
Issue Date2017
Citation
British Journal of Ophthalmology, 2017, v. 101, n. 4, p. 453-456 How to Cite?
AbstractObjective To analyse the incidence, application and compliance to Royal College of Ophthalmologists retinopathy of prematurity (ROP) screening recommendations and subsequent treatment of ROP in a neonatal intensive care unit of a large tertiary referral centre in Hong Kong. Design A retrospective review was performed for all eligible premature neonates screened for ROP over a 7-year period from June 2008 to December 2015 in our local tertiary neonatal intensive care unit in Prince of Wales Hospital, Hong Kong, using the Royal College of Ophthalmologists ROP screening guideline (2008). Comparison between established UK and American screening guidelines were analysed for their applicability in our locality. Results A total of 602 infants were screened, with the incidence of ROP in 28.2% and type 1 ROP in 3.8%, and indirect diode laser performed in all type 1 ROP cases. Overall, adherence for screening criteria was 99.7%, with the average time to commence first screening at 4 weeks postnatal age. Of the 602 cases, 94 (15.6%) were early and 35 (5.8%) were later than the guidelines, of which only 5 (0.8%) of late-screened cases developed ROP requiring treatment. Subsequent treatment of ROP for all the late-screened cases was not delayed. Conclusions Current ROP screening using the UK guidelines (2008) is applicable, effective and safe to our predominantly Asian population in Hong Kong, with a low rate of delayed screening.
Persistent Identifierhttp://hdl.handle.net/10722/255975
ISSN
2015 Impact Factor: 3.036
2015 SCImago Journal Rankings: 1.873

 

DC FieldValueLanguage
dc.contributor.authorLuk, Abbie S.W.-
dc.contributor.authorYip, Wilson W.K.-
dc.contributor.authorLok, Julie Y.C.-
dc.contributor.authorLau, Henry H.W.-
dc.contributor.authorYoung, Alvin L.-
dc.date.accessioned2018-07-16T06:14:14Z-
dc.date.available2018-07-16T06:14:14Z-
dc.date.issued2017-
dc.identifier.citationBritish Journal of Ophthalmology, 2017, v. 101, n. 4, p. 453-456-
dc.identifier.issn0007-1161-
dc.identifier.urihttp://hdl.handle.net/10722/255975-
dc.description.abstractObjective To analyse the incidence, application and compliance to Royal College of Ophthalmologists retinopathy of prematurity (ROP) screening recommendations and subsequent treatment of ROP in a neonatal intensive care unit of a large tertiary referral centre in Hong Kong. Design A retrospective review was performed for all eligible premature neonates screened for ROP over a 7-year period from June 2008 to December 2015 in our local tertiary neonatal intensive care unit in Prince of Wales Hospital, Hong Kong, using the Royal College of Ophthalmologists ROP screening guideline (2008). Comparison between established UK and American screening guidelines were analysed for their applicability in our locality. Results A total of 602 infants were screened, with the incidence of ROP in 28.2% and type 1 ROP in 3.8%, and indirect diode laser performed in all type 1 ROP cases. Overall, adherence for screening criteria was 99.7%, with the average time to commence first screening at 4 weeks postnatal age. Of the 602 cases, 94 (15.6%) were early and 35 (5.8%) were later than the guidelines, of which only 5 (0.8%) of late-screened cases developed ROP requiring treatment. Subsequent treatment of ROP for all the late-screened cases was not delayed. Conclusions Current ROP screening using the UK guidelines (2008) is applicable, effective and safe to our predominantly Asian population in Hong Kong, with a low rate of delayed screening.-
dc.languageeng-
dc.relation.ispartofBritish Journal of Ophthalmology-
dc.titleRetinopathy of prematurity: Applicability and compliance of guidelines in Hong Kong-
dc.typeArticle-
dc.description.natureLink_to_subscribed_fulltext-
dc.identifier.doi10.1136/bjophthalmol-2016-308900-
dc.identifier.pmid27436782-
dc.identifier.scopuseid_2-s2.0-84978661425-
dc.identifier.volume101-
dc.identifier.issue4-
dc.identifier.spage453-
dc.identifier.epage456-
dc.identifier.eissn1468-2079-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats